AWM
CVS icon

Apollon Wealth Management’s CVS Health CVS Stock Holding History

Apollon Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47M Sell
43,238
-320
-0.7% -$28.6K 0.05% 283
2026
Q1 		$3.13M Sell
43,558
-774
-2% -$59.6K 0.05% 290
2025
Q4 		$3.52M Buy
44,332
+1,782
+4% +$140K 0.06% 260
2025
Q3 		$3.21M Buy
42,550
+8,216
+24% +$563K 0.06% 281
2025
Q2 		$2.37M Sell
34,334
-747
-2% -$49K 0.05% 323
2025
Q1 		$2.38M Buy
35,081
+1,717
+5% +$103K 0.05% 290
2024
Q4 		$1.5M Sell
33,364
-271
-0.8% -$15.2K 0.03% 405
2024
Q3 		$2.11M Buy
33,635
+1,608
+5% +$93.8K 0.06% 296
2024
Q2 		$1.89M Sell
32,027
-15,153
-32% -$948K 0.06% 307
2024
Q1 		$3.76M Sell
47,180
-2,136
-4% -$163K 0.12% 157
2023
Q4 		$3.89M Buy
49,316
+21,750
+79% +$1.55M 0.13% 147
2023
Q3 		$1.92M Sell
27,566
-2,013
-7% -$143K 0.1% 202
2023
Q2 		$2.04M Buy
29,579
+7,790
+36% +$554K 0.1% 209
2023
Q1 		$1.62M Sell
21,789
-3,560
-14% -$299K 0.1% 213
2022
Q4 		$2.36M Sell
25,349
-477
-2% -$46K 0.17% 132
2022
Q3 		$2.46M Sell
25,826
-207
-0.8% -$20.5K 0.2% 109
2022
Q2 		$2.41M Buy
26,033
+1,008
+4% +$98.4K 0.2% 110
2022
Q1 		$2.53M Buy
25,025
+5,938
+31% +$624K 0.18% 121
2021
Q4 		$1.97M Buy
19,087
+6,693
+54% +$618K 0.15% 158
2021
Q3 		$1.05M Buy
12,394
+6,555
+112% +$549K 0.14% 143
2021
Q2 		$487K Sell
5,839
-63
-1% -$5.16K 0.09% 222
2021
Q1 		$444K Sell
5,902
-4,119
-41% -$300K 0.09% 216
2020
Q4 		$684K Buy
+10,021
New +$652K 0.19% 105
2020
Q3 		– Sell
-1,207
Closed -$78K – 273
2020
Q2 		$78K Buy
+1,207
New +$76K 0.04% 199

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Apollon Wealth Management's CVS Position: Q2 2026 in Review

Apollon Wealth Management reduced its CVS Health (CVS) stake by 0.73% in Q2 2026, selling an estimated $28.6K and leaving 43,238 shares worth $4.47M. The position accounts for 0.05% of the portfolio, ranked #283.

Apollon Wealth Management first reported a position in CVS in Q2 2020 and has held it in 24 quarters since. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Apollon Wealth Management held 43,238 shares of CVS Health worth $4.47M as of Q2 2026.
  • Apollon Wealth Management sold 320 CVS Health shares in Q2 2026, an estimated $28.6K.
  • CVS Health made up 0.05% of Apollon Wealth Management's portfolio in Q2 2026, its #283 holding.
  • Apollon Wealth Management first reported a position in CVS Health in Q2 2020 and has held it in 24 quarters since.
  • 567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.